Short-term outcomes following massive small bowel resection: our experience of 23 cases
DOI:
https://doi.org/10.18203/2320-6012.ijrms20261325Keywords:
Short bowel syndrome, Teduglutide, Parenteral nutrition, Mesenteric ischemia, Intestinal adaptation, Intestinal failureAbstract
Background: Short bowel syndrome (SBS) is a condition where a significant portion of the small intestine is lost/ absent, either congenitally or secondary to surgical resection. Complications arising due to the short length of the remnant bowel account for the high morbidity and mortality. In this case series, we describe our experience with 23 patients who underwent major intestinal resection.
Methods: Retrospective data were retrieved from departmental records from January 2017 to June 2024 of patients who underwent major small bowel resection at Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry with a remnant small bowel length of <200cm.
Results: After excluding patients with incomplete records, data from 23 patients were analyzed. Mesenteric ischemia due to thrombosis of the superior mesenteric artery or vein was the most common etiology behind massive bowel resection. Most of the patients required intensive care in the immediate postoperative period, with ventilator support. The wound related complications included superficial and deep surgical site infection (52.2%), wound dehiscence (21.7%), and stomal necrosis (26.1%). Dyselectrolytemia, in the form of hyponatremia, was common in Type I (90%) and Type II SBS (80%), whereas it had a lower incidence in Type III SBS (28.6%), p value = 0.023. Early postoperative mortality occurred in 5 patients.
Conclusions: The present case series shows the high morbidity and mortality associated with massive small bowel resection. Early initiation of enteral feeds, with or without parenteral supplementation, may help prevent dependence on parenteral nutrition and is associated with lower morbidity and mortality.
References
Siddiqui MT, Al‐Yaman W, Singh A, Kirby DF. Short‐bowel syndrome: epidemiology, hospitalization trends, in‐hospital mortality, and healthcare utilization. JPEN J Parenter Enteral Nutr. 2021;45(7):1441-55.
Pironi L. Definitions of intestinal failure and the short bowel syndrome. Best Pract Res Clin Gastroenterol 2016;30(2):173-85.
Pironi L. Definition, classification, and causes of short bowel syndrome. Nutr Clin Pract 2023;38:S9-16.
Massironi S, Cavalcoli F, Rausa E, Invernizzi P, Braga M, Vecchi M. Understanding short bowel syndrome: Current status and future perspectives. Dig Liver Dis 2020;52(3):253-61.
Amiot A, Messing B, Corcos O, Panis Y, Joly F. Determinants of home parenteral nutrition dependence and survival of 268 patients with non-malignant short bowel syndrome. Clin Nutr 2013;32(3):368-74.
Nightingale J, Woodward JM. Guidelines for management of patients with a short bowel. Gut 2006;55(suppl 4):iv1-2.
Brandt CF, Hvistendahl M, Naimi RM, Tribler S, Staun M, Brobech P, et al. Home parenteral nutrition in adult patients with chronic intestinal failure: the evolution over 4 decades in a tertiary referral center. JPEN J Parenter Enteral Nutr 2017;41(7):1178-87.
Mundi MS, Kuchkuntla AR, Hurt RT. Metabolic complications of home parenteral nutrition and short bowel syndrome: metabolic bone disease, hyperglycemia, dehydration, and d-lactic acidosis. In: Corrigan ML, Roberts K, Steiger E (ed) Adult Short Bowel Syndrome. United States: Elsevier B.V.; 2019:109-127.
Huijbers A, Wanten GJ. Hepatobiliary complications of intestinal failure and home parenteral nutrition. In: Corrigan ML, Roberts K, Steiger E (ed) Adult Short Bowel Syndrome. United States: Elsevier B.V.; 2019:129-145.
Opilla M. Catheter-related complications of home parenteral nutrition. In: Corrigan ML, Roberts K, Steiger E (ed) Adult Short Bowel Syndrome. United States: Elsevier B.V.; 2019:147-163.
Abu-Elmagd KM, Armanyous SR, Fujiki M, Parekh NR, Osman M, Scalish M, et al. Management of five hundred patients with gut failure at a single center: surgical innovation versus transplantation with a novel predictive model. Ann Surg 2019;270(4):656-74.
Wing VK, Song Y, Xiang C, Liu X, Macaulay D, Ponsillo M, et al. Incidence of catheter-related complications among Japanese patients with central venous catheters as well as patients with short bowel syndrome. Clin Exp Gastroenterol 2018;28:439-45.
Pironi L, Sasdelli AS. Intestinal failure-associated liver disease. Clin Liver Dis 2019;23(2):279-91.
Jeejeebhoy KN. Management of short bowel syndrome: avoidance of total parenteral nutrition. Gastroenterol 2006;130(2):S60-6.
Bioletto F, D’Eusebio C, Merlo FD, Aimasso U, Ossola M, Pellegrini M, et al. Efficacy of teduglutide for parenteral support reduction in patients with short bowel syndrome: a systematic review and meta-analysis. Nutr. 2022;14(4):796.
Howard L. Home parenteral nutrition: survival, cost, and quality of life. Gastroenterol. 2006;130(2):S52-9.
Vantini I, Benini L, Bonfante F, Talamini G, Sembenini C, Chiarioni G, et al. Survival rate and prognostic factors in patients with intestinal failure. Dig Liver Dis 2004;36(1):46-55.
Pironi L, Joly F, Forbes A, Colomb V, Lyszkowska M, Baxter J, et al. Long-term follow-up of patients on home parenteral nutrition in Europe: implications for intestinal transplantation. Gut. 2011;60(1):17-25.
Schalamon J, Mayr JM, Höllwarth ME. Mortality and economics in short bowel syndrome. Best Pract Res Clin Gastroenterol. 2003;17(6):931-4.